CN102198182A - Medicament for treatment of interstitial pneumonia - Google Patents
Medicament for treatment of interstitial pneumonia Download PDFInfo
- Publication number
- CN102198182A CN102198182A CN2011101491238A CN201110149123A CN102198182A CN 102198182 A CN102198182 A CN 102198182A CN 2011101491238 A CN2011101491238 A CN 2011101491238A CN 201110149123 A CN201110149123 A CN 201110149123A CN 102198182 A CN102198182 A CN 102198182A
- Authority
- CN
- China
- Prior art keywords
- lung
- medicine
- treatment
- interstitial pneumonia
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Disclosed is a Chinese medicine for the treatment of interstitial pneumonia. The medicine is an oral liquid prepared by the following steps: decocting dandelion, patrinia herb, barbat skullcap, polygonum cuspidatum and almond with water to obtain a decoction solution, condensing the decoction solution and adding conventional excipients, adding purified water until the content of crude drugs reaches 1 g/ml, and carrying out embedding and sterilizing. The Chinese medicine in the invention is natural, pure, safe and nontoxic, and has no dependency. Active ingredients in the Chinese medicine can fully expel killed viruses in a lung out of a body, remove deposits which stagnate in and block capillary vessels of the lung for a long time, open blood vessels in the lung, strengthen the functions of blood supply and oxygen supply of the lung, and thoroughly improves the environment in the lung. According to clinical observation, the effective rate of the medicine is 90%.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of pneumonia, particularly a kind of is the Chinese medicine of the treatment interstitial pneumonia of crude drug preparation with Chinese medicine.
Background technology
Interstitial pneumonia is meant the inflammation of last air flue, alveolar and interstitial lung eventually.Its symptom: heating, rapid breathing, lasting dry cough has monolateral chest pain, and chest pain when deeply breathing and coughing has expectorant or a large amount of expectorant in a small amount, may contain the blood streak.The traditional Chinese medical science thinks that this disease is because the spleen kidney deficiency, and behind the exopathogen visitor lung, deficiency of the lung heresy is stayed, and then gas the moon is impaired for a long time, and the lungs venation block is declared respectful mistake department, and expectorant is turbid is reluctant to leave the lung key, or dries up and to cause dry cough frequent, the stupid card of coughing that becomes touching difficulty to heal in deficiency of YIN Tianjin.The maximum characteristics of interstitial pneumonia are: insidious onset, carrying out property increase the weight of, finally cause lung, heart failure.Primary disease becomes " incurable disease " that can not prevent, be difficult for early discovery, bad treatment, progressive injury.Because doctor trained in Western medicine never has special effective method for the treatment interstitial pneumonia, can't cure, the final result of western medical treatment all is respiratory failure and heart failure to occur, causes death, so primary disease is called as " inferior cancer ".
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine for the treatment of interstitial pneumonia, natural pure, the safety non-toxic of this medicine does not have dependency.Its effective ingredient can be external with the malicious fully eliminating of the lung that is killed, and removes the deposit of long-term silt resistance at pulmonary's blood capillary, and unobstructed pulmonary vascular is enhanced pulmonary's blood supply oxygen supply function, thoroughly improves environment in the pulmonary.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Herba Taraxaci 25～35 Herba Patriniae 40～50
Herba Scutellariae Barbatae 10～20 Rhizoma Polygoni Cuspidati 25～35
Semen Armeniacae Amarum 8～14.
Optimum range:
Herba Taraxaci 30 Herba Patriniae 45 Herba Scutellariae Barbataes 15
Rhizoma Polygoni Cuspidati 30 Semen Armeniacae Amarums 12.
Said medicine can be made on the pharmaceutics any dosage form such as tablet, pill, powder, capsule, the present invention is oral liquid preferably.
The concrete preparation method of above-mentioned each component being made oral liquid of the present invention is:
With above-mentioned medicaments in part by weight mix homogeneously, decoct with water 2～4 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, and cold preservation is left standstill, and gets supernatant and filters, add conventional adjuvant in the filtrate, mixing, adding purified water is 1g/ml to containing the crude drug amount, oral liquid formulations is made in embedding, sterilization.
Using method: oral, each 1, every 15ml, every day three times.
Interstitial pulmonary fibrosis belongs to the traditional Chinese medical science " lung-QI stagnation syndrome " consumptive lung disease " category, " Huang di's Canon of Medicine. the numbness opinion " record: " and BI-syndrome related to skin endlessly, in close in lung, then be lung-QI stagnation syndrome, consumptive lung disease ... the excess of QI numbness of panting is gathered at lung ", " lung-QI stagnation syndrome person, stuffy sensation with restlessness is breathed heavily and is vomitted." according to patient's clinical symptoms and pathological features, the traditional Chinese medical science is called " lung-QI stagnation syndrome " with this disease.Numbness person, numbness hinders obstructed meaning also.From the variation of its microcosmic, interstitial lung chronic inflammatory disease, immune complex deposit are at interstitial lung, and fibroblast and collagen protein hypertrophy finally cause lung tissue to be destroyed, and this is that numbness hinders the expectorant stasis of blood poison heresy in lung.Because the evil impatency of expectorant stasis of blood poison is in interstitial lung, the lung network is obstructed, and impairment of dispersing and descending function of the lung must not be inhaled, breathe hard and movingly then increase the weight of, dry cough, breathe heavily and symptom such as suppress so dyspnea, gas occur.In the prescription of the present invention, Herba Taraxaci heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation can be used for the pyretic toxicity card, kind especially removing heat from the liver; The Herba Patriniae heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, stasis-dispelling and pain-killing.And the hepatitis virus resisting effect is arranged, and can promote liver cell regeneration, prevent hepatocellular degeneration, improve the effect of liver function; The Herba Scutellariae Barbatae heat-clearing and toxic substances removing, dissipating blood stasis hemostasis, inducing diuresis to remove edema.The function of Rhizoma Polygoni Cuspidati is heat-clearing and toxic substances removing, promoting blood circulation to restore menstrual flow.More than all medicines share, be used for the treatment of interstitial pneumonia cure rate height, no Western medicine preparation is to side effect such as human internal organ infringements, also drug resistance such as antibiotic-free.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 20 routine pneumonia patients that the curative effect of medicine of the present invention is carried out clinical observation.
20 routine pneumonia patient man 13 examples, women 7 examples are the patient who adopts the Western medicine glucocorticoid to carry out treatment as the primary disease drug of first choice.17 examples are effective, but wherein hormone side effect has appearred in 5 examples.This 20 routine pneumonia patient of back uses medicine of the present invention to treat, every day 3 times, each 1.
Criterion of therapeutical effect: according to " the clinical research guideline of new Chinese medicine treatment interstitial pneumonia " regulation, efficacy determination disappears based on shade in two lungs, with reference to change situations such as symptom, signs, is divided into healing, produce effects, effective, invalid level Four.Cure: symptom and sign all disappear.Produce effects: symptom and sign are obviously improved.Effectively: symptom and sign have certain improvement.Invalid symptom and sign all do not have improvement.
Observe patient's logotype 30 days through treatment.3 examples are cured, 13 routine produce effects, and 2 examples are effective, and 2 examples are invalid.Effective percentage 90%.Without any side effect and untoward reaction.Illustrate that drug effect of the present invention is more effective than Western medicine.
The specific embodiment
Embodiment 1
Get Herba Taraxaci 30g, Herba Patriniae 45g, Herba Scutellariae Barbatae 15g, Rhizoma Polygoni Cuspidati 30g, Semen Armeniacae Amarum 12g cleans with clear water, decoct with water 3 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, cold preservation is left standstill, get supernatant and filter, add conventional adjuvant, mixing in the filtrate, adding purified water is 1g/ml to containing the crude drug amount, and oral liquid formulations is made in embedding, sterilization.
Embodiment 2
Get Herba Taraxaci 35g, Herba Patriniae 50g, Herba Scutellariae Barbatae 15g, Rhizoma Polygoni Cuspidati 30g, Semen Armeniacae Amarum 12g cleans with clear water, decoct with water 3 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, cold preservation is left standstill, get supernatant and filter, add conventional adjuvant, mixing in the filtrate, adding purified water is 1g/ml to containing the crude drug amount, and oral liquid formulations is made in embedding, sterilization.
Claims (3)
1. Chinese medicine for the treatment of interstitial pneumonia is characterized in that:
Medicine of the present invention is that feedstock production obtains by following parts by weight of traditional Chinese medicines:
Herba Taraxaci 25～35 Herba Patriniae 40～50
Herba Scutellariae Barbatae 10～20 Rhizoma Polygoni Cuspidati 25～35
Semen Armeniacae Amarum 8～14.
2. the Chinese medicine of treatment interstitial pneumonia according to claim 1, its feature is being that described medicine is made oral liquid.
3. the preparation method of the medicine of the described treatment interstitial pneumonia of claim 2 is: with above-mentioned medicaments in part by weight mix homogeneously, decoct with water 2～4 times, each 1～2 hour, collecting decoction, filter, filtrate is condensed into the clear paste of 70 ℃ of relative densities 1.15～1.18, and cold preservation is left standstill, and gets supernatant and filters, add conventional adjuvant in the filtrate, mixing, adding purified water is 1g/ml to containing the crude drug amount, oral liquid formulations is made in embedding, sterilization.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101491238A CN102198182A (en) | 2011-06-03 | 2011-06-03 | Medicament for treatment of interstitial pneumonia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101491238A CN102198182A (en) | 2011-06-03 | 2011-06-03 | Medicament for treatment of interstitial pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102198182A true CN102198182A (en) | 2011-09-28 |
Family
ID=44659337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101491238A Pending CN102198182A (en) | 2011-06-03 | 2011-06-03 | Medicament for treatment of interstitial pneumonia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102198182A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102861136A (en) * | 2012-09-14 | 2013-01-09 | 郭玲玲 | Medicament for treating pneumonia and preparation method thereof |
| CN103550664A (en) * | 2013-10-31 | 2014-02-05 | 钱丹丹 | Traditional Chinese medicine for treating pneumonia |
| CN111084836A (en) * | 2019-12-17 | 2020-05-01 | 清华德人西安幸福制药有限公司 | Application of combination of thermionic acid and antibiotics in intervention of antibacterial action against pathogenic bacteria |
-
2011
- 2011-06-03 CN CN2011101491238A patent/CN102198182A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102861136A (en) * | 2012-09-14 | 2013-01-09 | 郭玲玲 | Medicament for treating pneumonia and preparation method thereof |
| CN103550664A (en) * | 2013-10-31 | 2014-02-05 | 钱丹丹 | Traditional Chinese medicine for treating pneumonia |
| CN111084836A (en) * | 2019-12-17 | 2020-05-01 | 清华德人西安幸福制药有限公司 | Application of combination of thermionic acid and antibiotics in intervention of antibacterial action against pathogenic bacteria |
| CN111084836B (en) * | 2019-12-17 | 2021-12-10 | 清华德人西安幸福制药有限公司 | Application of combination of thermionic acid and antibiotics in intervention of antibacterial action against pathogenic bacteria |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103055052B (en) | Cream for treating burn and scald and preparation method of cream | |
| CN103463297B (en) | A kind of Chinese medicine composition for the treatment of eczema scrotum and its production and use | |
| CN103830636A (en) | Pharmaceutical composition for treating bronchitis and asthma | |
| CN102198182A (en) | Medicament for treatment of interstitial pneumonia | |
| CN104042713B (en) | A kind of Chinese medicine composition for the treatment of bronchial asthma | |
| CN100386106C (en) | Medicine for treating acne and its preparation | |
| CN101926903A (en) | Chinese medicine preparation for curing facial paralysis | |
| CN101732425B (en) | Externally-applied medicine composite for psoriasis | |
| CN105148235A (en) | Traditional Chinese medicine combination treating postpartum hemorrhage | |
| CN104491268A (en) | Traditional Chinese medicine capsule for treating lymphoma and preparation method thereof | |
| CN104771734B (en) | A kind of Chinese medicine composition for treating chronic cardiopulmonary disease | |
| CN103028088B (en) | Traditional Chinese medicine composition for treating coronary heart disease and angina | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN105816603A (en) | Traditional Chinese medicine composition for treating postpartum hemorrhage | |
| CN105687659A (en) | Medicine patch for treating cesarean-postoperative abdominal incision sclerosis | |
| CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN105147861A (en) | Traditional Chinese medicinal composition and oral preparation for treating viral skin diseases and preparation method of oral preparation | |
| CN104688901A (en) | Traditional Chinese medicine topical agent for preventing constipation of patients with acute myocardial infarction and nursing method | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN102813774B (en) | Traditional Chinese medicine combination for treating stony goiter and preparation method thereof | |
| CN101703590B (en) | Chinese medicament for treating coronary disease | |
| CN107823351A (en) | A kind of Chinese medicine preparation for treating pain in waist and lower extremities and preparation method thereof | |
| CN105770434A (en) | Traditional Chinese medicine composition for treating dental ulcer | |
| CN108030843A (en) | A kind of Chinese medicine for treating pulmonary emphysema |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110928 |